🟢 MBX Biosciences is trading 4.18% up with no clear catalyst identified

On September 28, 2026, MBX Biosciences is trading 4.18% higher at $55.87, with no confirmed catalyst identified.

• The company’s investor-relations release list shows its latest release was dated September 9, not September 28.
• Major U.S. indexes are down, leaving the stock’s gain against the broader market direction. No clear company-specific or market catalyst was identified.